Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohort

Purpose: Large and consistent evidence supports the role of body mass index (BMI) as a prognostic and predictive indicator in breast cancer. However, there is paucity of data specifically referred to women diagnosed at a young age across the different disease settings. We investigated the impact of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Biol Ther
Egile Nagusiak: D'Aiuto, Massimiliano, Chirico, Andrea, De Riggi, Michele Antonio, Frasci, Giuseppe, De Laurentiis, Michelino, Di Bonito, Maurizio, Vici, Patrizia, Pizzuti, Laura, Sergi, Domenico, Maugeri-Saccà, Marcello, Barba, Maddalena, Giordano, Antonio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2016
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910911/
https://ncbi.nlm.nih.gov/pubmed/26934127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2016.1156265
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak